AIMS: A major public health concern associated with schizophrenia is the long-term disability that involves an inability to function independently in the community. An individual's self-awareness of functional impairment may be a significant factor contributing to long-term disability. In fact, subjective interpretation of one's illness impacts treatment participation and adherence, and is linked to poor outcomes. However, it remains unclear how illness-related functional impairment is perceived by individuals prior to the onset of psychosis. This study aims to examine the relationship between clinician-based and self-report assessments of functioning, as well as the contribution of clinical symptoms to this relationship in individuals at clinical high-risk for psychosis. METHODS: The Sheehan Disability Scale, a self-rated instrument, was used to measure disruption in daily functioning in social and role functioning due to symptoms in a sample of 73 treatment-seeking patients at clinical high-risk for psychosis and 50 healthy controls. RESULTS: Relative to healthy controls, clinical high-risk patients self-reported significant disruptions in social and role functioning. In addition, a specific relationship emerged in that clinician-rated measures of functioning and depression were related to subjective functioning. CONCLUSIONS: These findings suggest that clinical high-risk patients are significantly disturbed by their illness. Self-reported disruption of daily functioning was associated with clinician-rated functioning and depressive symptoms, further highlighting the impact of functional impairments on the level of distress experienced by patients in the early phases of the illness. Intervention strategies that repair functional impairment before the onset of psychosis may prevent long-term disability.
AIMS: A major public health concern associated with schizophrenia is the long-term disability that involves an inability to function independently in the community. An individual's self-awareness of functional impairment may be a significant factor contributing to long-term disability. In fact, subjective interpretation of one's illness impacts treatment participation and adherence, and is linked to poor outcomes. However, it remains unclear how illness-related functional impairment is perceived by individuals prior to the onset of psychosis. This study aims to examine the relationship between clinician-based and self-report assessments of functioning, as well as the contribution of clinical symptoms to this relationship in individuals at clinical high-risk for psychosis. METHODS: The Sheehan Disability Scale, a self-rated instrument, was used to measure disruption in daily functioning in social and role functioning due to symptoms in a sample of 73 treatment-seeking patients at clinical high-risk for psychosis and 50 healthy controls. RESULTS: Relative to healthy controls, clinical high-risk patients self-reported significant disruptions in social and role functioning. In addition, a specific relationship emerged in that clinician-rated measures of functioning and depression were related to subjective functioning. CONCLUSIONS: These findings suggest that clinical high-risk patients are significantly disturbed by their illness. Self-reported disruption of daily functioning was associated with clinician-rated functioning and depressive symptoms, further highlighting the impact of functional impairments on the level of distress experienced by patients in the early phases of the illness. Intervention strategies that repair functional impairment before the onset of psychosis may prevent long-term disability.
Authors: H Meng; B G Schimmelmann; B Mohler; M Lambert; E Branik; E Koch; M Karle; M Strauss; U Preuss; F Amsler; P Riedesser; F Resch; D Bürgin Journal: Acta Psychiatr Scand Date: 2006-10 Impact factor: 6.392
Authors: Ricardo E Carrión; Terry E Goldberg; Danielle McLaughlin; Andrea M Auther; Christoph U Correll; Barbara A Cornblatt Journal: Am J Psychiatry Date: 2011-05-02 Impact factor: 18.112
Authors: G Paul Amminger; Miriam R Schäfer; Konstantinos Papageorgiou; Claudia M Klier; Sue M Cotton; Susan M Harrigan; Andrew Mackinnon; Patrick D McGorry; Gregor E Berger Journal: Arch Gen Psychiatry Date: 2010-02
Authors: Robert Arbuckle; Mark A Frye; Martin Brecher; Björn Paulsson; Kitty Rajagopalan; Susan Palmer; Alessio Degl' Innocenti Journal: Psychiatry Res Date: 2008-11-29 Impact factor: 3.222
Authors: Ricardo E Carrión; Barbara A Cornblatt; Danielle McLaughlin; Jeremy Chang; Andrea M Auther; Ruth H Olsen; Daniel C Javitt Journal: Schizophr Res Date: 2015-02-23 Impact factor: 4.939
Authors: Joseph S DeLuca; Derek M Novacek; Laura H Adery; Shaynna N Herrera; Yulia Landa; Cheryl M Corcoran; Elaine F Walker Journal: Evid Based Pract Child Adolesc Ment Health Date: 2022-03-23
Authors: Dana M Allswede; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Barbara A Cornblatt; Daniel H Mathalon; Thomas McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Tyrone D Cannon Journal: Am J Psychiatry Date: 2019-09-06 Impact factor: 18.112
Authors: Elizabeth Thompson; Pamela Rakhshan; Steven C Pitts; Caroline Demro; Zachary B Millman; Kristin Bussell; Jordan DeVylder; Emily Kline; Gloria M Reeves; Jason Schiffman Journal: Schizophr Res Date: 2018-09-08 Impact factor: 4.939